Exciting new research at the University of Southern Queensland has found that anthocyanin in the Queen Garnet significantly reduced the effects of inflammatory bowel disease (IBD) in rats. These promising findings may provide relief for the one in 250 Australians living with IBD.
IBD, not to be confused with IBS (irritable bowel syndrome), is a group of conditions where there is inflammation of the intestines. These conditions are Crohn’s disease (can affect any part of the intestines) and ulcerative colitis (affects the large intestine). In Crohn’s disease, the inflammation often covers the entire gut wall, whereas in ulcerative colitis the inflammation tends to be isolated to the inner lining of the gut.
In USQ’s study, consumption of the anthocyanin from QG resulted in significantly reduced inflammation of the intestines, improved regeneration of surrounding intestinal tissue, and improved stool consistency. This is because the anthocyanin is able to inhibit inflammatory cell signalling, effectively inhibiting oxidative stress and inflammation. It is also important for promoting signalling pathways that activate antioxidant compounds.
Crohn’s & Colitis Australia predicts the prevalence of IBD will increase by 25% by 2022. While more research is needed, the findings from this study offer hope that IBD sufferers might get relief by adding anthocyanin to their diet.